Author: Dipender Gill; Marios Arvanitis; Paul Carter; Ana I Hernandez Cordero; Brian Jo; Ville Karhunen; Susanna C Larsson; Xuan Li; Sam M Lockhart; Amy M Mason; Evanthia Pashos; Ashis Saha; Vanessa Tan; Verena Zuber; Yohan Bosse; Sarah Fahle; Ke Hao; Tao Jiang; Philippe Joubert; Alan C Lunt; Willem hendrik Ouwehand; David J Roberts; Wim Timens; Maarten van den Berge; Nicholas A Watkins; Alexis Battle; Adam S Butterworth; John Danesh; Barbara E Engelhard; James E Peters; Don Sin; Stephen Burgess
Title: ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study Document date: 2020_4_14
ID: 1kkpx108_15
Snippet: Identification of a mechanistic basis by which such exposures affect risk and severity of COVID-19 could provide useful insight for disease prevention and treatment. This could be used to inform optimal medication use and strategies for shielding vulnerable individuals, as well as improving the evidence base for public health campaigns......
Document: Identification of a mechanistic basis by which such exposures affect risk and severity of COVID-19 could provide useful insight for disease prevention and treatment. This could be used to inform optimal medication use and strategies for shielding vulnerable individuals, as well as improving the evidence base for public health campaigns.
Search related documents:
Co phrase search for related documents- disease prevention and health campaign: 1, 2, 3, 4, 5, 6
- disease prevention and public health campaign: 1, 2, 3, 4
- disease prevention and severity risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disease prevention and treatment disease prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- disease prevention and useful insight: 1
- evidence base and severity risk: 1
- health campaign and public health campaign: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- health campaign and severity risk: 1, 2
- mechanistic basis and severity risk: 1
- public health campaign and severity risk: 1, 2
- severity risk and treatment disease prevention: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date